Telomir Pharmaceuticals is a preclinical stage company focused on reversing biological aging and degenerative diseases. The company released test results that showed the company's primary treatment, Telomir-1, showed the ability to reverse the suppression of a master tumor suppressor gene that is silenced in many aggressive cancers. This continues the exciting preclinical data that should lead to clinical trials in the near future.
